Concepedia
Statistics
Publications
6
Citations
213
H-Index
Active since
2017
Affiliations
Northwest University(Current)
Forma Therapeutics (United States)
Sun Yat-sen University
Guangdong Pharmaceutical University
Regend Therapeutics (China)
Junyi Pu is an author at Northwest University specializing in oncology, molecular oncology, and medicine.
Publications per year
2017–2023
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
Weining Weng, Tao Meng, Qianqian Zhao et al. · Cancer Discovery · 2023 · 76 citations
Pharmacy, Oncology, Pharmacology +17
Transcriptome profiling identified differentially expressed genes and pathways associated with tamoxifen resistance in human breast cancer
Xin Men, Jun Ma, Tong Wu et al. · Oncotarget · 2017 · 44 citations · Full text
Medicine, Molecular Biology, Oncology +13
<i>KANK1</i> regulates paclitaxel resistance in lung adenocarcinoma A549 cells
Junyi Pu, Jianfeng Shen, Zihua Zhong et al. · Artificial Cells Nanomedicine and Biotechnology · 2020 · 33 citations · Full text
Medicine, Oncology, Pharmacology +17
AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors
Weining Weng, Tao Meng, Junyi Pu et al. · Molecular Cancer Therapeutics · 2023 · 26 citations · Full text
Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells
Shaojia Wen, Xun Wang, Yamin Wang et al. · Artificial Cells Nanomedicine and Biotechnology · 2018 · 20 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 6